Journal of Applied Pharmaceutical Research
Vol. 14 No. 5 (2026)

Virtual screening, molecular dynamics, and preliminary in vitro validation of losartan as a potential ZEB1-targeting compound in cancer

Poongothai Sundramoorthy (Department of Pharmaceutics, Faculty of Pharmacy, Vellalar College of Pharmacy, Erode, Tamil Nadu, India)
Gayathri Kumararaja (Department of Pharmaceutics, Faculty of Pharmacy, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India)



Article Info

Publish Date
31 Oct 2026

Abstract

Background: An essential transcription factor linked to tumor growth, the epithelial–mesenchymal transition (EMT), metastasis, and treatment resistance in a number of malignancies is zinc finger E-box-binding homeobox 1 (ZEB1). By virtually screening FDA-approved medications, the current study sought to find possible ZEB1-targeting compounds and assess the main candidate's biological activity in TNBC cells. Methodology: ZEB1 was screened against around 30,000 FDA-approved medications using molecular docking. Molecular dynamics (MD) simulations & protein–ligand interaction tests were used to examine the top-ranked molecule further in order to assess binding stability. MDA-MB-231 cells were employed for preliminary biological validation using the MTT cytotoxicity assay and quantitative RT-PCR measurement of ZEB1 expression. Results and Discussion: Losartan demonstrated the highest docking affinity toward ZEB1 among the investigated compounds, with a docking score of −10.9 kcal/mol. The stability of the protein–ligand complex was further supported by molecular dynamics modeling, which demonstrated persistent protein–ligand interactions during the simulation period. MDA-MB-231 cells exhibited concentration-dependent cytotoxicity following Losartan treatment, with an IC50 of 115 µg/mL. Quantitative RT-PCR analysis showed a numerical decrease in normalized ZEB1 mRNA expression in Losartan-treated cells compared with untreated controls, with a fold change of 0.38; however, this difference was not statistically significant (p = 0.5755). Conclusion: The computational findings support the potential interaction of Losartan with ZEB1, while the preliminary in vitro results demonstrated cytotoxic activity, and a numerical change in normalized ZEB1 mRNA expression did not reach statistical significance. This study highlights the potential of drug-repurposing approaches for identifying candidate compounds for further investigation in ZEB1-associated cancer pathways.

Copyrights © 2026






Journal Info

Abbrev

joapr

Publisher

Subject

Medicine & Pharmacology

Description

Journal of Applied Pharmaceutical Research (JOAPR) is an official publication of Creative Pharma Assent (CPA). It is an open access, peer review online international journal. JOAPR is primarily focused on multiple discipline of pharmaceutical sciences (Pharmaceutics, Pharmaceutical Technology, ...